Lilly Ultra Long acting Insulin Phase III Clinical Success
六月清晨搅
发表于 2024-5-16 20:55:31
223
0
0
[Phase III clinical success of Eli Lilly ultra long-acting insulin] Eli Lilly announced that the weekly injection of ultra long-acting insulin Insulin Efstora Alfa in the treatment of type II diabetes, two phase III clinical QWINT-2 and QWINT-4, obtained positive data.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Will Tesla Shanghai Super Factory Launch Phase III Project? Industry insider: I haven't heard of this news yet
- Will Tesla Shanghai Super Factory Launch Phase III Project? Industry insider: I haven't heard of this news yet
- Will Tesla Shanghai Super Factory Launch Phase III Project? Industry insider: I haven't heard of this news yet
- European regulators recommend approval of insulin once a week for treatment of diabetes
- Novo Nordisk Ultra Long acting Insulin Global First Batch Expected Within Two Months
- Before the United States! What is the safety and efficacy of the world's first weekly insulin injection approved in China
- The world's first weekly insulin preparation has encountered setbacks in the United States, and the FDA requires additional information, with no hope of approval this year
- Novo Nordisk reportedly faces US congressional review for halting sales of long-acting insulin Levemir in the US
- Novo Nordisk's world's first weekly insulin preparation, Novo Nordisk, has been included in the national medical insurance catalog
